{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:35:39Z","timestamp":1761845739188},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Immunohistochemical expression of P53 protein is so closely related to status of mutation of P53 gene which is tightly linked with pathogenesis of nephroblastoma or Wilms tumor. This study aims to determine the immunohistochemical expression of P53 protein and its predictors in formalin-fixed paraffin-embedded tissue blocks of patients with nephroblastoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>A series of 83 histologically diagnosed cases of nephroblastoma from formalin-fixed paraffin-embedded tissue blocks archived at the Department of Pathology, Makerere University, in Kampala, Uganda, were analyzed. Monoclonal anti-p53 antibody (DO-7, DAKO) was used to assess the expression of P53 protein expression. Multivariable logistic regression analysis was performed to determine the predictors of P53 protein immunohistochemical expression, and statistical significance was considered when <jats:italic>p<\/jats:italic>-value was less than 0.05.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Most (42.2%, <jats:italic>n<\/jats:italic>\u2009=\u200935) of the cases were in advanced tumor stages (III\u2013V), and almost one-quarter (21.7%, <jats:italic>n<\/jats:italic>\u2009=\u200918) of the cases were in high-risk group. The immunohistochemical expression of P53 protein was (8.4%, <jats:italic>n<\/jats:italic>\u2009=\u20097), and there were more (83.3%, <jats:italic>n<\/jats:italic>\u2009=\u20095) positive anaplastic cases for P53 protein compared with (2.6%, <jats:italic>n<\/jats:italic>\u2009=\u20092) of P53 expression for non-anaplastic cases. High risk (<jats:italic>AOR<\/jats:italic>\u2009=\u20093.42, 95% <jats:italic>CI<\/jats:italic>\u2009=\u20097.91\u201312.55, <jats:italic>p<\/jats:italic>\u2009=\u20090.037) and anaplasia (<jats:italic>AOR<\/jats:italic>\u2009=\u20091.41, 95% <jats:italic>CI<\/jats:italic>\u2009=\u200913.85\u20134.46, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) were potential predictors of immunohistochemical expression of P53 protein.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Most of patients with nephroblastoma in resources-limited settings are diagnosed with advanced clinical stages. Association of P53 protein with anaplasia found in this study indicates the possibility of having novel target therapy for treatment of patients with anaplastic form of nephroblastoma with a focus of identifying molecules that lead to its suppression in such subpopulations of patients with nephroblastoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43046-023-00183-2","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:01:56Z","timestamp":1690761716000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunohistochemical expression of P53 protein in nephroblastoma: a predictor of unfavorable prognosis"],"prefix":"10.1186","volume":"35","author":[{"given":"Emmanuel D.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Yahaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Advera I.","family":"Ngaiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Othieno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okwi A.","family":"Livex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"issue":"3","key":"183_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/PAP.0000000000000017","volume":"21","author":"T Al-Hussain","year":"2014","unstructured":"Al-Hussain T, Ali A, Akhtar M. Wilms tumor: an update. Adv Anat Pathol. 2014;21(3):166\u201373.","journal-title":"Adv Anat Pathol"},{"key":"183_CR2","doi-asserted-by":"crossref","unstructured":"Ooms AHAG, Vujani\u0107 GM, D\u2019hooghe E, Collini P, L\u2019hermin\u00e9-Coulomb A, Vokuhl C, et al. Renal tumors of childhood\u2014a histopathologic pattern-based diagnostic approach. Cancers (Basel). 2020;12(3):1\u201320.","DOI":"10.3390\/cancers12030729"},{"issue":"3","key":"183_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pedneo.2014.01.003","volume":"55","author":"SS Chiou","year":"2014","unstructured":"Chiou SS. Malignant renal tumors in childhood. Pediatr Neonatol. 2014;55(3):159\u201360.","journal-title":"Pediatr Neonatol"},{"issue":"9","key":"183_CR4","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/cncr.26554","volume":"118","author":"AN Ali","year":"2012","unstructured":"Ali AN, Diaz R, Shu HK, Paulino AC, Esiashvili N. A Surveillance, Epidemiology and End Results (SEER) program comparison of adult and pediatric Wilms\u2019 tumor. Cancer. 2012;118(9):2541\u201351.","journal-title":"Cancer"},{"issue":"12","key":"183_CR5","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1002\/ijc.33147","volume":"147","author":"K Nakata","year":"2020","unstructured":"Nakata K, Colombet M, Stiller CA, Pritchard-Jones K, Steliarova-Foucher E. Incidence of childhood renal tumours: an international population-based study. Int J Cancer. 2020;147(12):3313\u201327.","journal-title":"Int J Cancer"},{"key":"183_CR6","unstructured":"Humberto LL. Pediatric Surgical handbook. Puerto Rico; 2001. p. 35\u201335."},{"key":"183_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/pbc.24948","volume":"61","author":"DC Aronson","year":"2014","unstructured":"Aronson DC, Hadley GP. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa. Pediatr Blood Cancer. 2014;61:987\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"183_CR8","unstructured":"Okello I, Tibenderana R, Lubega A, Tuhairwe E, Situma M. Wilms tumour among children attending Mbarara Regional Referral Hospital: clinico-pathological characteristics and outcome at the end of treatment. East Cent African J Surg. 2019;24(1):28\u201334. Available from: https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=tnh&AN=149954549&site=ehost-live&scope=site."},{"issue":"5","key":"183_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/cas.12910","volume":"107","author":"C Deng","year":"2016","unstructured":"Deng C, Dai R, Li X, Liu F. Genetic variation frequencies in Wilms\u2019 tumor: a meta-analysis and systematic review. Cancer Sci. 2016;107(5):690\u20139.","journal-title":"Cancer Sci"},{"issue":"3","key":"183_CR10","first-page":"1","volume":"5","author":"AK Saxena","year":"2020","unstructured":"Saxena AK, Singh V, Kumar V, Singh P, Tiwari M, Kumar R, et al. Penetrance of WT1 and WT2 gene mutation and loss of heterozygosity in Wilms tumors in Indian population. Int J Cancer Res Ther. 2020;5(3):1\u20137.","journal-title":"Int J Cancer Res Ther"},{"issue":"4","key":"183_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4238\/gmr18958","volume":"20","author":"AK Saxena","year":"2021","unstructured":"Saxena AK, Kumar V, Tiwari M, Kumar S, Kumar U. Research article non-synonymous de novo gene mutations in Wilms\u2019 tumor: identification and characterization of new variants of WT1 and WT2 loci in Indian population. Genet Mol Res. 2021;20(4):1\u201310.","journal-title":"Genet Mol Res"},{"issue":"3","key":"183_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2350\/12-08-1245-CR.1","volume":"16","author":"SD Popov","year":"2013","unstructured":"Popov SD, Vujanic GM, Sebire NJ, Chagtai T, Williams R, Vaidya S, et al. Bilateral wilms tumor with TP53- related anaplasia. Pediatr Dev Pathol. 2013;16(3):217\u201323.","journal-title":"Pediatr Dev Pathol"},{"key":"183_CR13","doi-asserted-by":"publisher","unstructured":"Gadd S, Huff V, Skol AD, Renfro LA, Fernandez C V., Mullen EA, et al. Genetic changes associated with relapse in favorable histology Wilms tumor: a Children\u2019s Oncology Group AREN03B2 study. Cell Rep Med. 2022;3(6):100644. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100644","DOI":"10.1016\/j.xcrm.2022.100644"},{"issue":"3","key":"183_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/0189-6725.170185","volume":"12","author":"AT Atanda","year":"2015","unstructured":"Atanda AT, Anyanwu LJC, Atanda OJ, Mohammad AM, Abdullahi LB, Farinyaro AU. Wilms\u2019 tumour: determinants of prognosis in an African setting. African J Paediatr Surg. 2015;12(3):171\u20136.","journal-title":"African J Paediatr Surg"},{"key":"183_CR15","doi-asserted-by":"crossref","unstructured":"Darwish A, Alemam D, Sheta H. Role of expression of p53 and Ki67 in the progression of Wilms tumor; correlation with survival. Int J Cancer Biomed Res. 2021;0(0):0\u20130.","DOI":"10.21608\/jcbr.2021.46401.1081"},{"issue":"February","key":"183_CR16","first-page":"1","volume":"10","author":"Y Shi","year":"2021","unstructured":"Shi Y, Norberg E, Vakifahmetoglu-Norberg H. Mutant p53 as a regulator and target of autophagy. Front Oncol. 2021;10(February):1\u201318.","journal-title":"Front Oncol"},{"key":"183_CR17","doi-asserted-by":"crossref","unstructured":"Govender D, Hariial P, Hadley GP, Chetty R. p53 protein expression in nephroblastomas\u00a0: a predictor of poor prognosis. 1998;77:314\u20138.","DOI":"10.1038\/bjc.1998.48"},{"issue":"6","key":"183_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4103\/nmj.NMJ_134_19","volume":"60","author":"A Mremi","year":"2019","unstructured":"Mremi A, Yahaya J, Abraham Z, Mwakigonja A. The role of a minimum immunohistochemical antibody panel in confirming undifferentiated nasopharyngeal carcinoma:a cross-sectional study at the Muhimbili National Hospital, Dar-es-Salaam, Tanzania. Niger Med J. 2019;60(6):279.","journal-title":"Niger Med J"},{"issue":"2","key":"183_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mpo.1276","volume":"38","author":"MV Gordan","year":"2002","unstructured":"Gordan MV, Bengt S, Dieter H, Anna K, Ivo L, de Jan K. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol. 2002;38(2):79\u201382.","journal-title":"Med Pediatr Oncol"},{"key":"183_CR20","unstructured":"Jadali F, Sayadpour D, Rakhshan M, Karimi A, Rouzrokh M, Shamsian BS, et al. Kidney diseases immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor. 2011;5(3):149\u201353."},{"issue":"7","key":"183_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3889\/oamjms.2018.278","volume":"6","author":"D Nikolova","year":"2018","unstructured":"Nikolova D, Chalovska-Ivanova V, Genadieva-Dimitrova M, Eftimov A, Jovanovik R, Janevska V. TP53 mutation in correlation to immunohistochemical expression of P53 protein in patients with hepatocellular carcinoma. Open Access Maced J Med Sci. 2018;6(7):1181\u20136.","journal-title":"Open Access Maced J Med Sci"},{"key":"183_CR22","doi-asserted-by":"crossref","unstructured":"Krishna OHR, Kayla G, Abdul Aleem M, Malleboyina R, Reddy Kota R. Immunohistochemical expression of Ki67 and p53 in wilms tumor and its relationship with tumor histology and stage at presentation. Patholog Res Int. 2016;2016: Article ID 6123951.","DOI":"10.1155\/2016\/6123951"},{"issue":"2","key":"183_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/0971-5851.99744","volume":"33","author":"RN Das","year":"2012","unstructured":"Das RN, Chatterjee U, Sinha SK, Ray AK, Saha K, Banerjee S. Study of histopathological features and proliferation markers in cases of Wilms\u2019 tumor. Indian J Med Paediatr Oncol. 2012;33(2):102\u20136.","journal-title":"Indian J Med Paediatr Oncol"},{"key":"183_CR24","doi-asserted-by":"publisher","unstructured":"Salama A, Kamel A. Evaluation of nuclear unrest and p53 immunostaining in Wilms\u2019 tumor. J Egypt Natl Canc Inst. 2011;23(1):31\u20139. https:\/\/doi.org\/10.1016\/j.jnci.2011.07.005.","DOI":"10.1016\/j.jnci.2011.07.005"},{"key":"183_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.14694\/EdBook_AM.2014.34.215","volume":"34","author":"JS Dome","year":"2014","unstructured":"Dome JS, Perlman EJ, Graf N. Risk stratification for Wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ B. 2014;34:215\u201323.","journal-title":"Am Soc Clin Oncol Educ B"},{"issue":"1","key":"183_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1590\/S1676-24442013000100008","volume":"49","author":"AP Percicote","year":"2013","unstructured":"Percicote AP, El Ghoz LF, Almeida TVR, Freitas AKE, Gugelmin ES, De Noronha L. Immunohistochemical expression of p53, BCL-2, BAX and VEGFR1 proteins in nephroblastomas. J Bras Patol e Med Lab. 2013;49(1):50\u20136.","journal-title":"J Bras Patol e Med Lab"},{"issue":"10","key":"183_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0109924","volume":"9","author":"M Maschietto","year":"2014","unstructured":"Maschietto M, Williams RD, Chagtai T, Popov SD, Sebire NJ, Vujanic G, et al. TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia. PLoS ONE. 2014;9(10):1\u20138.","journal-title":"PLoS ONE"},{"issue":"5","key":"183_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1369\/0022155421995600","volume":"69","author":"B Aditi","year":"2021","unstructured":"Aditi B, Zachary M, Kelly BE, Ping G, Daniel CR, Dana RV, et al. Impact of preanalytical factors on the measurement of tumor tissue biomarkers using immunohistochemistry. J Histochem Cytochem. 2021;69(5):297\u2013320.","journal-title":"J Histochem Cytochem"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-023-00183-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-023-00183-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-023-00183-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:02:26Z","timestamp":1690761746000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-023-00183-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1186\/s43046-023-00183-2","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Institutional Review Board (IRB) of the School of Biomedical Science of Makerere College of Health Sciences (MakCHS) (reference: SBS-HDREC-418). Being a retrospectives study, obtaining consent from the patients was waived by the chairperson of the IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}